ArticleJournal of lipid and atherosclerosis2025
Dyslipidemia Fact Sheet in South Korea, 2024.
Article in Journal of lipid and atherosclerosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Carbohydrate-dependent interaction between AMY1A/AMY2B copy number variation and APOA5 rs651821 associated with hypertriglyceridemia in Korean middle-aged adults.BMC nutrition · 2026Article
- Distribution of LDL-Cholesterol Levels and Their Associations With Cardiovascular Outcomes in Young Adults Under 40 Years in South Korea: A Nationwide Cohort Study.Journal of lipid and atherosclerosis · 2026Article
- The MASLD Journey in the General Population: Linkage-to-Care and Patient-Reported Uptake of Fibrosis Risk Assessment.Liver international : official journal of the International Association for the Study of the Liver · 2026Article
- Efficacy and safety of metabolic bariatric surgery in patients aged ≥55 years: a multicenter retrospective cohort study in East Asians.Annals of surgical treatment and research · 2026Article
- Types of Soy Foods Are Differently Associated With Lipid Abnormalities in Korean Adults.Journal of lipid and atherosclerosis · 2026Article
- Effects of Cricket Powder Supplementation on Gut Microbiota in High-Fat Diet-Fed Mice.Foods (Basel, Switzerland) · 2026Article
- Age- and sex-specific attributable impact of modifiable risk factors on atherosclerotic cardiovascular disease in Korea: a nationwide population-based cohort study.The Lancet regional health. Western Pacific · 2026Article
- Comparative pharmacokinetics of a candesartan/amlodipine/atorvastatin fixed-dose combination 8 mg/5 mg/10 mg versus separate tablets in healthy subjects: a partial replicated crossover study.Translational and clinical pharmacology · 2026Article
- A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions.Journal of lipid and atherosclerosis · 2026Review
- A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZetFrontiers in endocrinology · 2026Observational
- A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions.Korean circulation journal · 2026Review
- Plasma Exchange as an Adjunctive Therapeutic Option for Severe and Refractory Antineutrophil Cytoplasmic Antibody-Negative Microscopic Polyangiitis and Granulomatosis with Polyangiitis.Medicina (Kaunas, Lithuania) · 2025Article
- Age-related trajectories of blood lipids and lipoproteins by sex, region, and waist circumference changes in Korea: a longitudinal cohort study.Epidemiology and health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to examine the prevalence of dyslipidemia, evaluate management patterns, and explore related health behaviors among South Korean adults through an analysis of the 2024 Dyslipidemia Fact Sheet. Methods: This study utilized data from the Korea National Health and Nutrition Examination Survey (2007-2022) and the National Health Insurance Service-National Sample Cohort (2002-2019) to assess lipid profiles, trends in prevalence, management indicators, and health behaviors in South Koreans aged 20 and over. The 2005 Korean demographic distribution was applied as the reference for age standardization. Results: The crude prevalence of dyslipidemia during 2016-2022 was 40.9% under standard criteria, increasing to 47.4% when modified high-density lipoprotein-cholesterol criteria for women were applied. From 2007 to 2022, the age-adjusted prevalence of hypercholesterolemia rose markedly from 8.8% to 22.4%, while the crude prevalence reached 27.4%. Indicators of hypercholesterolemia management showed improvement, with awareness, treatment, and control rates of 68.0%, 61.2%, and 54.1%, respectively. Comorbidity analysis demonstrated a markedly higher prevalence of dyslipidemia in adults with diabetes (87.0%), hypertension (72.4%), and obesity (55.2%). Health behavior evaluation revealed suboptimal adherence to dietary and physical activity recommendations. Conclusion: Despite advances in detection and treatment, dyslipidemia remains highly prevalent in South Korea, particularly among individuals with metabolic comorbidities. Given the insufficient adherence to dietary and physical activity guidelines, strengthened strategies for prevention and management are warranted, with an emphasis on lifestyle modification and aggressive treatment approaches in high-risk groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.